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Lack of efficacy of triclabendazole 
against Fasciola hepatica is present on 
sheep farms in three regions of 
England, and Wales
Juriah Kamaludeen,1 John Graham-Brown,  2 Nathalie Stephens,3 Josephine Miller,4 Alison Howell,2 
Nicola J Beesley,2 Jane Hodgkinson,5 Jane Learmount,6 Diana Williams7
The liver fluke Fasciola hepatica is a parasitic trematode that has a major impact on livestock production and 
human health. Control of F hepatica is difficult and relies on anthelmintics, particularly triclabendazole, due 
to its efficacy against both adult and juvenile stages of the parasite. Emergence of triclabendazole-resistant F 
hepatica populations has been reported in a number of countries, including the UK, but the overall prevalence 
and distribution of triclabendazole resistance is unknown. In this study, the authors established the presence of 
reduced efficacy of triclabendazole in sheep flocks in England and Wales, using a validated composite faecal egg 
count reduction test. Seventy-four sheep farms were sampled from Wales, southwest, northwest and northeast 
England between Autumn 2013 and Spring 2015. F hepatica eggs were detected in samples from 42/74 farms. 
Evidence of a lack of efficacy of triclabendazole was detected on 21/26 farms on which the faecal egg count 
reduction test was completed, with faecal egg count reductions ranging from 89 per cent to 0per cent. Regression 
analysis suggested that both prevalence of F hepatica and lack of efficacy of triclabendazole were spatially 
correlated, with higher faecal egg counts and lower percentage reductions on farms located in the northwest of 
England, and Wales. Overall, the results show that reduced efficacy of triclabendazole is present across England 
and Wales, with a complete lack of therapeutic efficacy observed on 9/26 farms.
Introduction
Fasciola hepatica is a parasitic trematode of one health 
importance due to its global distribution and ability to 
infect multiple host species, including humans. It has 
a negative impact on food security through its effect 
on livestock productivity. In sheep and cattle, effects of 
infection range from clinical disease, with high levels 
of mortality and morbidity, to long-standing subclinical 
infections which reduce animal productivity, growth 
and fertility.1–3 Furthermore, human fasciolosis is 
considered a re-emerging neglected tropical disease, 
with estimates of 2.6–17 million individuals infected 
with Fasciola species and a further 91 million people at 
risk globally.4–6 
In temperate regions, including the UK, prevalence 
of liver fluke in livestock has been increasing both 
spatially and temporally in recent years.7 8 Such 
increases are largely attributed to changes in climatic 
conditions which favour the development of free-living 
stages of the parasite and its molluscan intermediate 
host, in Europe Galba truncatula.9 10
Control of fasciolosis is heavily reliant on the use of 
anthelmintic drugs, of which there are a limited number. 
Of these, the pro-benzimidazole triclabendazole (TCBZ) 
is commonly used, due to its unique efficacy against all 
stages of the parasite11; in sheep, TCBZ is effective at 
killing parasites from 2 days postinfection onwards.12 
TCBZ-resistant (TCBZ-R) F hepatica populations have 
been reported on multiple occasions across Europe, 
Australasia and South America.13–18 TCBZ-R has also 
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been documented in a case of human infection, with 
evidence to suggest this arose from TCBZ-R parasites 
infecting livestock in the locality.19
Neither the mode of action of TCBZ against F hepatica 
nor the mechanisms of resistance are known, and no 
new drugs or vaccines are likely to reach the market in 
the near future. A recent study examining the population 
structure of F hepatica in the UK demonstrated high 
levels of genetic diversity, a lack of population structure 
and high gene flow, suggesting resistance genes have 
the potential to spread rapidly within populations of 
F hepatica.20 It is therefore important that the extent 
of TCBZ resistance is known at a regional level, so that 
advice on quarantine treatments, and strategic use 
of TCBZ as part of an overall control programme for F 
hepatica, can be developed for the industry.
Here, the authors describe the results of a study 
to establish the presence and distribution of TCBZ 
resistance in four major sheep rearing regions of Great 
Britain, namely northwest (NW) England, northeast 
(NE) England, southwest (SW) England and Wales, 
using the composite faecal egg count reduction test 
(cFECRT) described by Daniel and others.21
Methods
Farm recruitment and sampling protocol
Farms were recruited into the study from three sources:
1. In NW England, farms were recruited through the Cumbria 
Farmers Network (CFN), an independent not-for-profit 
farming support network formed in 2006 which, at the time 
this study was conducted, had over 500 members ( www. 
thefarmernetwork. co. uk).
2. Names and addresses of 750 sheep farms from NE England, 
SW England and Wales were supplied by the Rapid Analysis 
and Detection of Animal-related Risks (RADAR) database. A 
random selection of 250 farms were invited to participate.
3. An additional 12 farms that were part of an Animal and 
Plant Health Agency (APHA) study investigating sustainable 
nematode control.22 These Sustainable Control of Parasites in 
Sheep (SCOPS) study farms were located in Wales, SW and 
NE England.
The fluke infection status of study farms was 
unknown before their recruitment. Farmers were either 
contacted by post (RADAR database) or phone (CFN 
and SCOPS farms). All participants were then sent an 
information sheet and asked to sign a consent form 
ahead of enrolment.
Farms recruited through CFN were sampled between 
August and November 2013. Those farms recruited 
through the RADAR database and SCOPS study were 
sampled between December 2014 and April 2015.
Farm visits by veterinary or APHA staff were 
arranged a minimum of 12 weeks after any previous 
flukicidal treatment. A validated cFECRT was used to 
estimate TCBZ treatment efficacy21; briefly, 20 randomly 
selected sheep from the same management group were 
gathered and penned in two groups of 10. After about 
20 minutes, the sheep were released and 10 individual 
faecal samples were collected from the floor of each 
pen. The weight of each sheep was measured and they 
were treated with TCBZ (FASINEX 5 per cent, Novartis, 
10 mg/kg/animal orally). If farms had a positive 
pretreatment egg count, the same 20 individuals were 
resampled at 21 days post-treatment. However, only 
data from farms with a pretreatment egg counts of 
greater than equal to 100 eggs per 100 g, that is, ≥1 epg, 
of faeces were used to calculate percentage faecal egg 
count reduction (%FECR), this being the previously 
established threshold.21 Results were sent back to each 
farm as soon as they were available.
All farm data were anonymised and stored in 
accordance with the UK Data Protection Act (1998).
Composite faecal egg sedimentation
Composite faecal samples were prepared from 10×5 g 
individual samples to give a total of 50 g. Faeces were 
homogenised in water and washed through stacked test 
sieves with decreasing apertures (710, 150 and 38 µm, 
respectively). The material retained in the 38 µm sieve 
was transferred to a 500 ml glass beaker, diluted to 
500 ml in water and left to stand for 4 minutes to allow 
sedimentation of fluke eggs. After this time water was 
poured off leaving a slurry of about 50 ml. The process 
was repeated until the supernatant was clear after the 
4 minutes sedimentation period. The sediment was 
transferred to a large petri dish, optionally stained 
with two to three drops of 10 per cent methylene blue, 
examined under a low power dissecting microscope (10x 
to 40x magnification) and the total number of F hepatica 
eggs recorded. In some samples, paramphistome 
(rumen fluke) eggs were observed. Distinction between 
egg types was made visually: F hepatica eggs have a 
golden brown coloration while parampistome eggs 
have a clear, uncolored appearance. Paramphistome 
eggs were not included in the final fluke egg counts.
The counts for the two composites were combined to 
give a total egg count per 100 g. Percentage faecal egg 
count reduction was only calculated if the pretreatment 
egg count was greater than equal to 1 epg using the 
following formula:
  %FECR=100−
((
post-treatment count
pretreatment count
)
× 100
)
  
A lack of drug efficacy was assumed if %FECR was 
less than 90 per cent.
Statistical analysis
To identify associations both for presence of F hepatica 
infection and efficacy of TCBZ treatment, results were 
compared with spatial and temporal explanatory 
variables by linear regression analysis.
Since composite fluke egg counts have been shown 
to correlate positively with group prevalence,21 23 
counts from the pretreatment sample collected from all 
farms (n=74) were used as an indicator of prevalence 
within each flock. Fluke egg counts were modelled 
as a response variable (Y) and compared with the 
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following explanatory variables (x): (i) farm GPS 
coordinates to assess the spatial distribution and (ii) a 
binomial term distinguishing sampling period for each 
farm (2013 or 2014/15) to allow potential variation 
in pasture infectivity between fluke seasons to be 
considered (autumn 2013 vs winter 2014/15). These 
explanatory variables were included simultaneously 
in a multivariable regression analysis. Before this, 
Box-Cox analysis determined a log(+1) transformation 
of the response variable (Y) was the most appropriate 
measure to ensure linear fit.24
Twenty-six fluke egg positive farms had initial 
fluke egg counts greater than equal to  100 and 
were resampled at 21 days post-TCBZ treatment. To 
investigate associations with reduced TCBZ efficacy 
using linear regression analysis, percentage reduction 
in egg count was calculated for those farms. For this 
analysis, where post-treatment egg counts exceeded 
pretreatment values, percentage reduction was taken 
to be zero. To avoid overparameterising this smaller 
dataset univariable analysis was performed, with 
log(+1) transformation of per cent reduction used as the 
response variable (Y) against each of the explanatory 
variables (x) described above.
All models were checked for goodness of fit by 
normality and residual plots. Results were interpreted 
from the mean and standard error (SE) of the coefficient 
(β) and P value estimated for each explanatory variable 
(x).
Results
A total of 74 farms were recruited to the study (table 1): 
20 farms were approached through the CFN, with 
16 farms ultimately sampled between August and 
November 2013. Forty-six farms from RADAR and 12 
from the SCOPS study were recruited and sampled 
between December 2014 and April 2015.
Positive faecal egg counts were obtained for 42 of 
the 74 farms sampled; counts ranged from 1 to greater 
than 20,000 eggs per 100 g faeces (table 1 and figure 1).
Twenty-six farms had pretreatment egg counts 
of greater than equal to 100, and the %FECR was 
calculated. Of these, 21 farms showed evidence of 
a reduction in drug efficacy. Twelve farms showed a 
reduction ranging from 89 per cent to 20 per cent and, 
on nine farms, TCBZ was completely ineffective, with 
post-treatment egg counts remaining the same or 
increasing (table 1 and figure 2).
Both the proportion of infected flocks and 
pretreatment faecal egg counts were highest in NW 
England, followed by Wales (figure  1). Multivariable 
linear regression analysis of (log(+1) transformed) 
pretreatment fluke egg counts revealed a strong spatial 
correlation, with a positive relationship found between 
egg counts and coordinates of increasing (northerly) 
latitude and decreasing (westerly) longitude (table 2). 
Table 1 Number and regional distribution of sampled and fluke egg 
positive farms at initial recruitment and at 21 days post-treatment with TCBZ
Pretreatment sampling
Post-treatment 
sampling: number of 
farms with <90% egg 
count reduction*
Number 
of farms 
sampled
Fluke 
positive
(1–100 eggs 
per 100 g)
Fluke positive
(≥100 eggs per 
100 g)*
NW England 17 3 13 13
Wales 17 4 3 2
SW England 17 5 0 NA
NE England 23 4 10 6
Total 74 16 26 21
Counts were based on two composite faecal samples, each comprised 10x 5 g individual samples. 
For repeated composite counts post-TCBZ treatment, faecal samples were taken from the same 
individuals sampled at pre treatment. 
*Only farms where pretreatment counts were ≥100 eggs per 100 g (≥1 epg) were used to calculate 
faecal egg count reduction post-treatment.
 NE, northeast; NW, northwest; SW, southwest; TCBZ, triclabendazole. 
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Figure 1 Composite faecal egg counts per 100 g faeces showing (A) spatial distribution of individual farms sampled (n=74) and (B) range of recorded composite counts. 
Colour in both plots correspond to recorded egg counts per 100 g, with white signifying an egg count of zero and orange to red demonstrating the observed range in 
positive counts from 1 to 21,664 eggs per 100 g faeces. Spatial coordinates jittered 0.15o by 0.09o latitude/longitude (approximately 10 km2).
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Year in which samples were collected was not found to 
be statistically significant in this multivariable analysis 
(table 2).
The FECRT was used on farms in three regions. Most 
of the farms where a lack of TCBZ efficacy was observed 
were situated in NW England (figure  2). Univariable 
spatial analysis of (log(+1) transformed) per cent FECR, 
with a statistically significant (P<0.05) relationship 
between decreasing percentage egg count reduction 
and decreasing (westerly) longitude (table 3). Samples 
collected in 2014/15 were also observed to have a 
higher percentage reduction when compared with those 
collected in 2013 (table 3).
None of the farms tested in SW England had 
pretreatment egg counts that met the minimum criteria 
of greater than equal to 1 epg faeces. However, the two 
farms in that region with the highest positive egg counts 
(78 eggs/100 g and 45 eggs/100 g, respectively) when 
resampled 21 days post-treatment recorded faecal egg 
counts of 51 and 12 eggs/100 g faeces, respectively, 
providing some evidence that TCBZ was not fully 
effective.
Discussion
This study is the first of its kind to demonstrate the 
presence and distribution of reduced TCBZ efficacy 
across two of the world’s leading sheep rearing countries 
(England and Wales). Of the 74 farms that participated in 
the study, 42 had positive fluke egg counts. A reduction 
in the efficacy of TCBZ was detected on 21 of 26 farms 
on which the full cFECRT was completed. On nine of 
those farms, egg counts either remained at pretreatment 
levels or increased 21 days after treatment, suggesting 
complete drug failure. Encouragingly, while reduced 
efficacy was demonstrated, TCBZ had some effect on 
egg counts on 12 farms. Linear regression analysis 
showed that, where the cFECRT was performed, reduced 
efficacy was most likely to occur in the more westerly 
parts of the UK, and that significantly higher fluke egg 
counts were also found in these regions, particularly 
NW England.
Based on the cFECRT, evidence of reduced TCBZ 
efficacy was detected on farms in NW England, NE 
England and Wales. None of the farms tested in SW 
England had pretreatment egg counts that met the 
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Figure 2 Percentage faecal egg count reduction (%FECR) at resampling 21 days post-treatment with TCBZ with (A) spatial distribution and (B) per cent reductions for 
individual farms and regions. %FECR were calculated for post-treatment positive farms with initial egg counts ≥100 fluke eggs per 100 g faeces (n=26). Colour in both 
plots corresponds to %FECR, with white to red signifying range in %FECR from 100% to 0%. For regression analysis, all negative percentage reductions (farms where 
counts increased at 21 day resampling) were taken to be zero. x indicates an absence of %FECR data on farms where initial composite counts of <100 eggs per 100 g of 
faeces were recorded. Hatched regions in (B) denote the categorisation of individual farms by region, and highlight farms from northwest (NW) England in (A). Spatial 
coordinates jittered 0.15o by 0.09o latitude/longitude (approximately 10 km2).
Table 2 Multivariable linear regression results for the response variable 
(Y) faecal egg count (log(+1) transformed)
Model ID Explanatory variable (x) 
Coefficient 
value (β) SE P value 
Multi_lm_1 Spatial coordinates: 
Longitude (easting) −1.232 0.541 0.026*
Latitude (northing) 1.486 0.423 <0.001†
2013 vs 2014/15 −1.763 1.129 0.123
Coefficients (β) indicate the relationship between each explanatory variable (x) and the response 
variable (Y) with associated standard error (SE) and P value.
*Signifies P<0.05 (95% CI).
†Signifies P<0.005 (99.5% CI).
Table 3 Univariable linear regression results for the response variable (Y) 
percentage faecal egg count reduction (log(+1) transformed)
Model ID Explanatory variable (x) 
Coefficient 
value (β) SE P value 
Uni_lm_1 Spatial coordinates: 
Longitude (easting) 1.519 0.522 0.008*
Latitude (northing) −1.028 0.523 0.061
Uni_lm_2 2013 vs 2014/15 −2.394 0.648 0.001†
Coefficients (β) indicate the relationship between each explanatory variable (x) and the response 
variable (Y) with associated standard error (SE) and P value.
*Signifies P<0.01 (99% CI).
†Signifies P<0.005 (99.5% CI).
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minimum criteria of 1 epg faeces.21 However, while they 
did not contribute per cent FECR data, the two farms 
in that region with the highest positive egg counts did 
provide evidence suggesting that TCBZ was not fully 
effective. This led us to the conclusion that reduced 
efficacy of TCBZ was evident in Wales and all three 
regions of England investigated.
Thirteen of the 21 farms where reduced efficacy was 
detected were from NW England. Our multivariable 
regression analysis suggested that farms in the north 
and west were more likely to have higher FECs, while 
NW England region has previously been shown to have 
the highest fluke prevalence of anywhere in England 
and Wales.25 26 Hence, it is likely that in such areas 
use of flukicides like TCBZ would be more extensive 
and the selection pressure for resistance will be high. 
It is important to note, however, evidence of reduced 
TCBZ efficacy was also detected in regions typically 
considered to be of low or medium risk of fluke infection 
also (NE and SW England, respectively). It is suggested 
that animal movements, which have increased in 
recent years, have helped introduce F hepatica into 
areas of the UK where it is not traditionally found, 
particularly if farms are involved in agrienvironment 
schemes promoting wetland management.27 Movement 
of animals may also introduce TCBZ-resistant parasites 
into areas where drug selection pressure may be low 
and therefore resistance not suspected.28 We have 
recently shown that there are high levels of genetic 
diversity, a lack of population structure and high gene 
flow in populations of F hepatica, suggesting that 
resistance genes have the potential to spread rapidly 
within and between populations of parasites affecting 
both sheep and cattle.20 These results therefore 
highlight the importance of testing and quarantine 
dosing sheep and cattle when they are moved onto a 
farm.
Participation in the study demanded considerable 
time and effort by farmers. In order to maximise 
recruitment, the authors therefore identified and 
approached suitable candidates through several 
routes, namely a farmers’ cooperative in NW England, 
the RADAR database and the SCOPS study being 
conducted by the APHA. While pre-existing knowledge 
of a farm’s fluke infection status was not a prerequisite 
for enrolment, it is possible that a number of the 
farmers who responded to the invitations may have 
already had evidence of fluke infection on their farms 
and/or suspected resistance to TCBZ. Consequently, 
potential for bias in this cohort cannot be excluded, 
meaning the proportion of farms demonstrating a lack 
of TCBZ efficacy should not necessarily be considered 
as representative of either the UK as whole, or its 
constituent regions. Similarly, the different methods 
of recruitment and the fact that the farms were tested 
over three different years could have introduced bias, 
particularly as the majority of farms from NW England 
were sampled in 2013 following the unusually wet year 
of 2012.29 30
For this study the authors used a validated cFECRT.21 
This is a useful field test that has been developed to 
evaluate TCBZ use in sheep. It does not prove that 
resistance is present, but demonstrates whether TCBZ 
is effective in reducing the faecal egg counts. Aside from 
indicating TCBZ resistance, alternative explanations for 
reduction in efficacy may relate to incorrect (under-)
dosing, faulty drenching equipment, etc. However, 
the trials conducted here were carried out by qualified 
staff, dosing guns were correctly calibrated, sheep 
were weighed and samples were collected according 
to the prescribed protocol. In the absence of other 
recommended protocols,31 the authors consider this test 
to be a useful tool in assessing TCBZ efficacy on farms.
In conclusion, this study demonstrates the spatial 
distribution of reduced triclabendazole efficacy in 
two major sheep producing countries of the world. Of 
74 farms tested, 21 showed evidence of reduced drug 
efficacy, suggesting TCBZ resistance is widespread and 
demonstrating the potential for this to become a major 
problem for sheep producers worldwide. These results 
also highlight the importance of promoting sustainable 
parasite control techniques in order to reduce selection 
for drug resistance and preserve TCBZ where it is still 
effective.
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